Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Avara has provided an update on Hurricane Maria's impact on the company's people and manufacturing facilities at our Arecibo, Puerto Rico site.
read more
Thursday, February 01, 2018
Nitto Denko Avecia announced the opening of a new corporate office in Cambridge, MA, to support its operations and corporate development activities.
read more
Avectas has entered into a collaborative agreement with The Simon Laboratory at UC Davis, California, USA (UCD) to engage in the characterization of cells engineered with Avectas' proprietary, non-viral SOLUPORE™ cell engineering platform.
read more
Avella announced it has been selected by Otsuka to distribute Jynarque, the FDA-approved therapy for patients diagnosed with autosomal dominant polycystic kidney disease.
read more
Averica Discovery Services Inc., an analytical development Contract Research Organization (CRO) based in the Greater Boston area, and Dalton Pharma Services, a contract provider of integrated chemistry, drug development, and manufacturing services ...
read more
Averica Discovery Services announced a new leadership team and the expansion into a larger facility to meet rising industry demand.
read more
Thursday, January 21, 2016
Averica Discovery, an analytical development contract research organization (CRO) with specialized expertise in small molecule analysis and purification, has announced the appointment of Cynthia Berger, Ph.D., to the newly-created position of Vice ...
read more
Avet Pharmaceuticals is initiating a voluntary recall of the following lots of Tetracycline HCl Capsules USP, 250 mg and 500 mg, 100-count bottles.
read more
AveXis has signed an agreement to purchase an advanced biologics therapy manufacturing campus in Colorado, further expanding its capacity as it prepares to launch Zolgensma®.
read more
Friday, February 22, 2019
AveXis will create 200 jobs as it expands its manufacturing center in Durham County, North Carolina, Governor Roy Cooper has announced.
read more
Avid Bioservices announced the appointment of Daniel Hart as chief financial officer.
read more
Avid Bioservices announced the appointment of Timothy Compton as chief commercial officer.
read more
Thursday, October 14, 2021
Avid Bioservices, a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, ...
read more
Tuesday, January 11, 2022
Avid Bioservices, Inc. announced the official opening of the second downstream processing suite within the company’s existing Myford North facility.
read more
Avid Bioservices announced the appointment of Maria Ebro Andreasen as Chief People Officer.
The appointment comes as Avid continues to scale its operations to meet increasing customer demand and support long-term growth.
read more